Talon Resources Targets Ontario Gold Growth After AIM Move and Eagle Lake Acquisition, CEO Says. Watch here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAmpeak Energy Regulatory News (AMP)

Share Price Information for Ampeak Energy (AMP)

Share Price is delayed by 15 minutes
Get Live Data
2.90    -0.10 (-3.33%)
Bid:
2.70
Ask:
3.10
Spread: 0.40 (14.815%)
Market Cap: £20.96m
AMP Live PriceLast checked at - London Stock Exchange

Intraday Ampeak Energy Share Chart

Update on Data Tern Patent Litigation

13 Apr 2011 07:00

RNS Number : 8002E
Amphion Innovations PLC
13 April 2011
 



Amphion Innovations plc

Update on U.S. Subsidiary, DataTern, Inc., Patent Litigation

 

 

London and New York, 13 April 2011 - DataTern, Inc., a wholly-owned subsidiary of Amphion Innovations plc (AIM: AMP) ("Amphion" or "the Company"), has successfully obtained settlements from suits brought in the U.S. against several, multi-national companies, for enforcement of its U.S. Patents 5,937,402 and 6,101,502 covering Object to Relational Database Mapping technology. Last week, Microsoft Corporation (NASD: MSFT) brought suit against DataTern claiming these patents are not infringed by Microsoft technology and are invalid. DataTerrn will strongly refute these claims by Microsoft and continue to enforce these patents against other infringers.

 

These patents are entitled to a presumption of validity and the 6,101,502 patent successfully completed a re-examination procedure in the U.S. Patent and Trademark Office in 2009. All 18 claims of this patent were reaffirmed and 26 new claims were added.

 

Richard Morgan, CEO of Amphion, said:

 

"DataTern has reached settlements with over 25 companies for over $17 million in license fees using its patented Object to Relational Database Mapping technology. We will vigorously defend the validity, and intend to prove infringement, of the DataTern patents."

 

 

For further information please contact:

Amphion Innovations

Charlie Morgan

+1 212 210 6224

 

Cardew Group

Tim Robertson

+44 (0)20 7930 0777

 

Seymour Pierce Limited, Nominated Advisor

Freddy Crossley/ Mark Percy

+44 (0)20 7107 8000

 

About Amphion Innovations plc

Amphion (LSE: AMP) builds shareholder value in high growth companies in the medical and technology sectors, by using a focused, hands-on company building approach, based on decades of experience in both the US and UK. Amphion has significant shareholding in 8 Partner Companies developing proven technologies targeting substantial commercial marketplaces, each in excess of $1 billion. Each Partner Company is chosen with the goal of achieving an exit valuation in excess of $100 million. The Amphion model has been refined to optimise the commercialisation of patents and other intellectual property within the Partner Companies. The Partner Companies collectively own or control over 200 separately identified pieces of intellectual property, a number that grows rapidly each year.

On the web: www.amphionplc.com

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCBIGDSSBBBGBD
Date   Source Headline
30th Apr 20082:58 pmRNSTotal Voting Rights
8th Apr 20087:00 amRNSPartner Company Fundraising
7th Apr 20083:46 pmRNSFundraising
26th Mar 200812:36 pmRNSDirector/PDMR Shareholding
13th Mar 20087:12 amRNSFinal Results
3rd Mar 20087:01 amRNSPrivateMarkets Fundraising
27th Feb 20088:00 amRNSNotice of Preliminary Results
31st Jan 20084:51 pmRNSTotal Voting Rights
17th Jan 20087:01 amRNSTrading Statement
7th Jan 20087:00 amRNSDirectors Dealings
30th Nov 20074:53 pmRNSTotal Voting Rights
12th Nov 20077:01 amRNSIssue of Equity
5th Nov 20071:59 pmRNSResult of EGM
5th Nov 20071:39 pmRNSResult of EGM
31st Oct 20075:49 pmRNSTotal Voting Rights-Amendment
31st Oct 20072:18 pmRNSTotal Voting Rights
29th Oct 20077:00 amRNSWellGen Series C Financing
12th Oct 20077:30 amRNSIssue of Equity
12th Sep 20077:01 amRNSInterim Results
28th Aug 200710:25 amRNSNotice of Results
22nd Aug 20077:01 amRNSChange of Adviser
16th Aug 20079:31 amRNSRe: AIM Rule 26
14th Aug 20077:00 amRNSFundraising
30th Jul 20077:01 amRNSRe: Series C Financing
12th Jul 20079:19 amRNSPatent Awarded
2nd Jul 20077:01 amRNSPlacing
7th Jun 20077:01 amRNSAGM Statement
21st May 20071:52 pmRNSRe: Symposium
21st May 20071:00 pmBUSApplied Genomics Paves the Way for Improved Prevention, Diagnosis, and Treatment of Disease
14th May 20074:25 pmBUSAmphion Innovations plc (LSE: ''AMP'') Announces First Annual Science & Business Symposium ''Building Market Value from the World of Genetics''
30th Apr 200711:02 amRNSDirector Shareholdings
11th Apr 200711:31 amRNSResearch Update
5th Apr 20071:00 pmBUSAmphion Innovations Partner Company Motif Biosciences Closes $1m Financing
5th Apr 20079:24 amRNSDirector/PDMR Shareholding
5th Apr 20077:01 amRNSRe: Series C Financing
23rd Mar 20072:42 pmBUSPort of Barbados Selects AXCESS to Provide Security Systems for the Cricket World Cup 2007
23rd Mar 20077:01 amRNSRe: Cricket World Cup
15th Mar 20077:01 amRNSFinal Results
26th Feb 20074:44 pmRNSNotice of Results
9th Feb 20077:00 amRNSRe: Financing
16th Jan 20073:25 pmBUSAmphion Innovations, plc Announces Creation of a Gulf-based Joint Venture
16th Jan 20073:19 pmBUSAmphion Innovations, plc Offers Trading Update
16th Jan 20077:01 amRNSJoint Venture
16th Jan 20077:00 amRNSTrading Update
8th Jan 20074:28 pmBUSAmphion Innovations plc Announces Fundraising
8th Jan 20071:08 pmRNSFundraising - Replacement
8th Jan 20077:00 amRNSFundraising
27th Nov 20063:04 pmBUSAmphion Innovations plc Acquires 35% Stake in Manchester Molecular Diagnostic Spin-out Company
27th Nov 20067:00 amRNSAcquires Stake in Company
13th Nov 20062:58 pmBUSAmphion Innovations plc Partner Company Supertron Acquires Spin Systems

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.